Pursuant to section 14(1) of the Agricultural Compounds and Veterinary Medicines Act 1997, the Director-General
of the New Zealand Food Safety Authority hereby gives notice that the following application has been made to register a trade name product under section 9(1) of the Agricultural Compounds and Veterinary Medicines Act 1997:
Trade Name: Novartis Broad Spectrum Oral Anthelmintic for Sheep
Active Ingredient and Concentration:
Formulation Type: Liquid
General Use Claim:
For the treatment and control of AAD-sensitive strains of gastro-intestinal roundworms (nematodes), including macrocyclic lactone (ML), benzimidazole (white), levamisole
(clear) and morantel-resistant strains.
Any person may make a written submission to the
director-general concerning this application. Under sections 16 and 17 of the Agricultural Compounds and Veterinary Medicines Act 1997, a written submission:
(a) must state in full the reasons for making the submission; and
(b) may state any decision sought on that application; and
(c) must be received by the director-general no later than 30 working days after the date of notification
in the New Zealand Gazette.
A copy of every submission will be forwarded to the applicant for the applicant’s information.
The following address is:
(a) where submissions on this application are to be sent; and
(b) where requests for copies of the public information relating to the application can be sent; and
(c) where public information relating to the application can be viewed; and
(d) the director-general’s address for service:
ACVM Group, New Zealand Food Safety
Authority, Level 5, South Tower, 68–86 Jervois Quay, Wellington. Postal Address: PO Box 2835, Wellington.
The applicant’s address for service is:
Novartis New Zealand Limited, 6–8 MacKelvie
Street, Grey Lynn, Auckland. Postal Address: Novartis New Zealand Limited, Private Bag 47909, Auckland 1034.
Dated at Wellington this 17th day of March 2008.
MAREE ZINZLEY, Programme Manager (Operations) (acting under delegated authority).